Cargando…

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo

SIMPLE SUMMARY: Neuroblastoma (NB) is the most common extracranial solid tumor in children, and the majority of patients with high-risk disease are unable to be cured. There is an urgent need to design novel therapeutics for NB patients. In NB, the RAS-MAPK pathway plays a crucial role in essential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yang, Zhao, Yanling, Choi, Jongmin, Shi, Zhongcheng, Guo, Linjie, Elizarraras, John, Gu, Andy, Cheng, Feng, Pei, Yanxin, Lu, Dai, Fabbri, Muller, Agarwal, Saurabh, Zhang, Chunchao, Jung, Sung Yun, Foster, Jennifer H., Yang, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688897/ https://www.ncbi.nlm.nih.gov/pubmed/36428626 http://dx.doi.org/10.3390/cancers14225534

Ejemplares similares

Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma
por: Wolfe, Zachary, et al.
Publicado: (2022)

Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies
por: Mendzelevski, Boaz, et al.
Publicado: (2018)

Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
por: Grierson, Patrick M, et al.
Publicado: (2022)

Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth
por: Chilamakuri, Rameswari, et al.
Publicado: (2022)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics
por: Sigaud, Romain, et al.
Publicado: (2022)

BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
por: Chilamakuri, Rameswari, et al.
Publicado: (2021)

Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo
por: Li, Haoyu, et al.
Publicado: (2016)

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma
por: Kim, Kwang Woon, et al.
Publicado: (2019)

Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth
por: Chilamakuri, Rameswari, et al.
Publicado: (2022)

Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action
por: Wang, Wei, et al.
Publicado: (2020)

The Different Impact of ERK Inhibition on Neuroblastoma, Astrocytoma, and Rhabdomyosarcoma Cell Differentiation
por: Lebedev, T. D., et al.
Publicado: (2021)

Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma
por: Tomolonis, Julie A, et al.
Publicado: (2023)

EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma
por: Sun, Wenjing, et al.
Publicado: (2017)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
por: Chen, Zhenghu, et al.
Publicado: (2017)

RDM1 promotes neuroblastoma growth through the RAS–Raf–MEK–ERK pathway
por: Xie, Guojin, et al.
Publicado: (2019)

Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
por: Chilamakuri, Rameswari, et al.
Publicado: (2022)

MYCN protein stability is a better prognostic indicator in neuroblastoma
por: Yang, Yi, et al.
Publicado: (2022)

Treatment of High-Risk Neuroblastoma
por: Krystal, Julie, et al.
Publicado: (2023)

Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis
por: Lopez-Delisle, Lucille, et al.
Publicado: (2018)

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2016)

High-Risk Neuroblastoma Treatment Review
por: Smith, Valeria, et al.
Publicado: (2018)

Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)

Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
por: Lu, Jiaxiong, et al.
Publicado: (2016)

Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma
por: Yu, Xiying, et al.
Publicado: (2020)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma
por: Ghaghada, Ketan B., et al.
Publicado: (2016)

LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma
por: Vieira, Gabriella Cunha, et al.
Publicado: (2015)

Perfiles de una política fiscal en el Estado de Chihuahua
por: Elizarraras González, Raúl
Publicado: (1966)

Targeting autophagy in neuroblastoma
por: Huang, Siqi, et al.
Publicado: (2020)

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
por: Mao, Xinfang, et al.
Publicado: (2016)

Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma
por: Vieira, Gabriella Cunha, et al.
Publicado: (2017)

Constitución y vida democrática / autora, María Eugenia Luna Elizarrarás.
por: Luna Elizarrarás, María Eugenia
Publicado: (2016)

Principios fundacionales de la educación primaria en México : primero y segundo Congresos Nacionales de Instrucción Pública 1889-1990 y 1890-1891 /
por: Luna Elizarrarás, Sara Minerva
Publicado: (2015)

Peligros geológicos más frecuentes en el estado de Veracruz
por: Rodríguez Elizarrarás, Sergio R.
Publicado: (2020)

Ley de comercio exterior : (análisis y comentarios) /
por: Velázquez Elizarrarás, Miguel Angel
Publicado: (2000)

Iguales en dignidad y derechos /
por: Luna Elizarrarás, María Eugenia
Publicado: (2017)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aehfus9j19iaf0erp38s56cre4